Healthcare stocks were trading in the negative zone, with the S&P BSE Healthcare index falling 24.6 points or 0.1% at 25597.98 at 13:51 IST.
Among the components of the S&P BSE Healthcare index, Syncom Formulations (India) Ltd (down 4.96%), Shalby Ltd (down 3.3%),Nectar Lifescience Ltd (down 3.24%),Medicamen Biotech Ltd (down 2.9%),Morepen Laboratories Ltd (down 2.56%), were the top losers. Among the other losers were Nureca Ltd (down 2.18%), Narayana Hrudayalaya Ltd (down 2%), Ind-Swift Laboratories Ltd (down 1.96%), Gland Pharma Ltd (down 1.75%), and Venus Remedies Ltd (down 1.68%).
On the other hand, Sequent Scientific Ltd (up 10.42%), Gufic BioSciences Ltd (up 8.17%), and Lasa Supergenerics Ltd (up 7.38%) moved up.
At 13:51 IST, the S&P BSE Sensex was up 471.77 or 0.78% at 61088.66.
The Nifty 50 index was up 132.05 points or 0.73% at 18187.8.
The S&P BSE Small-Cap index was up 130.36 points or 0.43% at 30564.38.
The S&P BSE 150 Midcap Index index was up 84.93 points or 0.94% at 9126.54.
On BSE,1776 shares were trading in green, 1626 were trading in red and 82 were unchanged.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app